VIDEO: Pass-through reimbursement changes coming in 2025

NEW YORK — In this Healio Video Perspective from OSN New York, John A. Hovanesian, MD, FACS, discusses an update on pass-through reimbursement.

Hovanesian said a CMS ruling that goes into effect in January 2025 will allow hospital outpatient department surgery to use products such as Dextenza (dexamethasone ophthalmic insert 0.4 mg, Ocular Therapeutix) and Omidria (phenylephrine 1% and ketorolac 0.3% intraocular solution, Rayner) and bill them separately from other services.

“If you do surgery in a hospital outpatient department, again you will have access to these important products that you want to use to help make surgery easier and safer for your patients,” Hovanesian said.

Published by:

Read more about

This post was originally published on this site